Genetic testing for inherited bleeding disorders
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial uses early genetic testing to find the cause of unexplained bleeding in people who may have an inherited bleeding disorder. The goal is to see if genetic testing can help diagnose these conditions sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a new patient referred for abnormal bleeding.
- A bleeding specialist has confirmed you have a history of abnormal bleeding and a family history of bleeding problems.
- Or, if there is no family history, the specialist has confirmed you have a severe bleeding history.
- You have not been previously diagnosed with an inherited bleeding disorder.
- Your bleeding is not caused by a medication or by significant kidney or liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Swiss study looks at people with unexplained bleeding by using a standardized bleeding score and taking a blood sample. It may help researchers better understand possible bleeding causes even when the reason isn’t clear yet.
This study follows people with inherited or acquired non-cancer blood disorders to better understand symptoms, causes, and how different treatments work over time. You may be placed into a disorder-specific group, depending on your diagnosis and testing results.
This study looks at genes and blood function in people with inherited (passed-down) problems with platelets, white blood cells, or blood clotting. It may help improve understanding of the cause of these conditions and how they work in the body.
This study is for people who have a history of unusual bleeding but whose standard blood tests have not found a known bleeding disorder. Researchers hope to learn more about what causes these unexplained bleeding problems.
This study looks at how the body stops bleeding or forms clots in people with bleeding or clotting disorders. It may help researchers understand these conditions better and improve evaluation tests.
This study looks at DNA (genetic material) in families affected by hereditary hemorrhagic telangiectasia (HHT). It aims to understand the genetic basis of HHT and why it runs in families.
Hear when a new Bleeding Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.